CVS Health (CVS) to Release Earnings on Wednesday

CVS Health (NYSE:CVS) is expected to release its Q1 2026 results before the market opens on Wednesday, May 6th. Analysts expect CVS Health to post earnings of $2.21 per share and revenue of $94.9783 billion for the quarter. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Interested persons can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 8:00 AM ET.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same quarter in the prior year, the business posted $1.19 EPS. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. On average, analysts expect CVS Health to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

CVS Health Trading Up 3.5%

CVS opened at $81.07 on Wednesday. CVS Health has a one year low of $58.35 and a one year high of $85.15. The company has a market cap of $103.90 billion, a P/E ratio of 58.75, a PEG ratio of 0.82 and a beta of 0.51. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The business’s 50-day simple moving average is $76.08 and its 200-day simple moving average is $77.90.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Investors of record on Thursday, April 23rd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. CVS Health’s dividend payout ratio is 192.75%.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Heavy bullish options flow ahead of earnings: unusually large call buying has been reported (28,507 calls traded, ~44% above average), suggesting some investors are positioning for an upside into CVS’s May earnings. Unusual Call Option Activity in CVS Ahead of Its Earnings Shows Investors are Bullish
• Positive Sentiment: Renewed optimism around earnings outlook and Medicare Advantage tailwinds: coverage notes link recent guidance reiteration/raise, Aetna margin recovery plans and a favorable CMS MA payment update as drivers supporting sentiment. CVS rises as investors focus on earnings outlook and Medicare Advantage tailwinds
• Positive Sentiment: Loyalty program revamp could boost retail & pharmacy margins: CVS announced a two?tiered benefits redesign for its loyalty program, which can increase customer retention and spend per visit if adoption is strong. CVS revamps loyalty program with two-tiered benefits
• Positive Sentiment: Operational/tech recognition: CVS won Gold (Enterprise AI) and Silver (Customer Experience AI) at the 2026 Stevie Awards — a signal the company’s AI investments are producing production?grade results that may improve efficiency and CX. CVS Health Wins Gold in Enterprise AI, and Silver in Customer Experience AI at 2026 Stevie®
• Positive Sentiment: Analyst/earnings previews lean constructive: sector stories and screens (Zacks/Yahoo) list CVS among names expected to beat Q1 estimates, adding to the positive narrative into results season. Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
• Neutral Sentiment: UnitedHealth and CVS standardize prior?authorization rules — could reduce friction for members/providers but impact to near?term revenue/margins is uncertain. UnitedHealth, CVS standardize prior authorization rules
• Neutral Sentiment: Executive hire: CVS named a former Sutter Health executive as its new security chief — operational governance move with limited immediate market impact. CVS taps former Sutter Health executive as security chief
• Neutral Sentiment: Industry/competitor context: coverage on Cardinal Health and healthcare ETFs offers broader sector signals but no direct company catalyst. William Blair Initiates Cardinal Health at Outperform
• Negative Sentiment: Large institutional portfolio moves noted in filings: some big managers trimmed CVS positions substantially in recent quarters (listed in institutional activity summaries), which could be a headwind if selling continues. CVS rises as investors focus on earnings outlook and Medicare Advantage tailwinds

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CVS. Wolfe Research dropped their price target on CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research note on Monday, March 2nd. The Goldman Sachs Group raised their price target on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Argus dropped their price target on CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. TD Cowen restated a “buy” rating on shares of CVS Health in a research note on Friday, March 13th. Finally, Leerink Partners restated an “outperform” rating and set a $98.00 price target on shares of CVS Health in a research note on Thursday, March 5th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.05.

Institutional Trading of CVS Health

A number of hedge funds have recently added to or reduced their stakes in the stock. CYBER HORNET ETFs LLC lifted its position in CVS Health by 4.1% during the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after acquiring an additional 134 shares during the period. Smartleaf Asset Management LLC lifted its position in CVS Health by 1.1% during the 2nd quarter. Smartleaf Asset Management LLC now owns 15,059 shares of the pharmacy operator’s stock worth $1,031,000 after acquiring an additional 164 shares during the period. Beck Mack & Oliver LLC lifted its position in CVS Health by 0.8% during the 4th quarter. Beck Mack & Oliver LLC now owns 21,248 shares of the pharmacy operator’s stock worth $1,686,000 after acquiring an additional 176 shares during the period. Zacks Investment Management lifted its position in CVS Health by 2.5% during the 4th quarter. Zacks Investment Management now owns 7,265 shares of the pharmacy operator’s stock worth $577,000 after acquiring an additional 178 shares during the period. Finally, Logan Capital Management Inc. lifted its position in CVS Health by 1.4% during the 3rd quarter. Logan Capital Management Inc. now owns 13,448 shares of the pharmacy operator’s stock worth $1,014,000 after acquiring an additional 182 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.